All Stories

  1. Brain age in bipolar disorders: Effects of lithium treatment
  2. Larger right inferior frontal gyrus volume and surface area in participants at genetic risk for bipolar disorders
  3. Connectivity of the anterior insula differentiates participants with first-episode schizophrenia spectrum disorders from controls: a machine-learning study
  4. Type 2 Diabetes Mellitus: A Potentially Modifiable Risk Factor for Neurochemical Brain Changes in Bipolar Disorders
  5. Insulin Resistance, Diabetes Mellitus, and Brain Structure in Bipolar Disorders
  6. Functional neuroanatomy of response inhibition in bipolar disorders – Combined voxel based and cognitive performance meta-analysis
  7. Effects of Lithium on Magnetic Resonance Imaging Signal Might Not Preclude Increases in Brain Volume After Chronic Lithium Treatment
  8. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder and major depressive disorder: a meta-analysis of family high-risk studies
  9. Why negative meta-analyses may be false?
  10. Genetic risk of suicidal behavior in bipolar spectrum disorder: analysis of 737 pedigrees
  11. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response
  12. Brain Structural Signature of Familial Predisposition for Bipolar Disorder: Replicable Evidence For Involvement of the Right Inferior Frontal Gyrus
  13. Loose ends of psychiatric research
  14. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis
  15. Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment
  16. Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study
  17. Discontinuation of lithium because of side effects
  18. White matter hyperintensities – from medical comorbidities to bipolar disorders and back
  19. Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: Meta-analysis
  20. Findings from bipolar offspring studies: methodology matters
  21. An admixture analysis of the age at index episodes in bipolar disorder
  22. White matter hyperintensities in affected and unaffected late teenage and early adulthood offspring of bipolar parents: A two-center high-risk study
  23. Early stages in the development of bipolar disorder
  24. Subgenual cingulate volumes in offspring of bipolar parents and in sporadic bipolar patients
  25. Can body mass index help predict outcome in patients with bipolar disorder?
  26. Amygdala volumes in mood disorders — Meta-analysis of magnetic resonance volumetry studies
  27. Neurocognitive functioning in the early stages of bipolar disorder: visual backward masking performance in high risk subjects
  28. Striatal volumes in affected and unaffected relatives of bipolar patients – high-risk study
  29. Resolution of Bipolar II and Panic Disorders Following Subarachnoid Hemorrhage
  30. Treatment of bipolar disorder: New perspectives
  31. Subgenual cingulate volumes in affected and unaffected offspring of bipolar parents
  32. Rapid cycling bipolar disorders in primary and tertiary care treated patients
  33. Pituitary volumes in relatives of bipolar patients
  34. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk
  35. Psychosis Induced by Low-Dose Bupropion: Sensitization of Dopaminergic System by Past Cocaine Abuse?
  36. Heterogeneity of the risk of suicidal behavior in bipolar‐spectrum disorders
  37. Prospective study of hippocampal volume and function in human subjects treated with corticosteroids
  38. Fronto‐cerebellar loop and declines in the performance intelligence scale
  39. Neuroanatomical abnormalities as risk factors for bipolar disorder
  40. Clinical correlates of current level of functioning in primary care‐treated bipolar patients
  41. Magnetic resonance relaxometry in monozygotic twins discordant and concordant for schizophrenia
  42. Hippocampal damage mediated by corticosteroids — a neuropsychiatric research challenge